Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
Autor: | Rupprecht, Rainer1,2 rainer.rupprecht@med.uni-muenchen.de, Papadopoulos, Vassilios3 vassilios.papadopoulos@mcgill.ca, Rammes, Gerhard2,4 rammes@mpipsykl.mpg.de, Baghai, Thomas C.1 Baghai@med.uni-muenchen.de, Fan, Jinjiang3 jinjiang.fan@mail.mcgill.ca, Akula, Nagaraju5 nagarajuakula@gmail.com, Groyer, Ghislaine6 ghislaine.groyer@inserm.fr, Adams, David7 david.adams@bct.aphp.fr, Schumacher, Michael6 michael.schumacher@inserm.fr |
---|---|
Zdroj: | Nature Reviews Drug Discovery. Dec2010, Vol. 9 Issue 12, p971-988. 18p. 6 Diagrams, 2 Charts. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |